Clinical Trials
3
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)Oxytocin on Approach Bias and Craving
- First Posted Date
- 2019-03-07
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- Jennifer Mitchell
- Registration Number
- NCT03865615
- Locations
- 🇺🇸
University of California, San Francisco, Berkeley, California, United States
Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress
Phase 2
Completed
- Conditions
- Alcohol Use DisorderAnxiety DisordersStress Disorders, Post-TraumaticSubstance Use Disorders
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-04-19
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Jennifer Mitchell
- Target Recruit Count
- 63
- Registration Number
- NCT02742532
- Locations
- 🇺🇸
Naval Medical Center San Diego, San Diego, California, United States
Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol Users
- First Posted Date
- 2016-04-15
- Last Posted Date
- 2020-09-21
- Lead Sponsor
- Jennifer Mitchell
- Target Recruit Count
- 62
- Registration Number
- NCT02740582
- Locations
- 🇺🇸
University of California, Berkeley, Berkeley, California, United States
🇺🇸University of California, San Francisco, San Francisco, California, United States
News
No news found